This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...
From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...
as the pharmaceutical industry continues to evolve ... we focus on the critical CMC issues and build programs that enhance ...
While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.
Discover the top sales and marketing intelligence solutions tailored for the pharmaceutical industry. Download our guide to predictive analytics and data-driven insights.
Healthcare has become digitized with telehealth and remote monitoring, EHRs and e-prescription and mobile health and wearable ...
The rapid progress in AI has also facilitated real-life applications within the pharmaceutical industry that may lead to ...
The consensus rating for Ultragenyx Pharmaceutical is Outperform, based on 6 analyst ratings. With an average one-year price target of $102.33, there's a potential 100.69% upside.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback